Literature DB >> 8617304

Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes.

J P Kelly1, G J Bancroft.   

Abstract

We have used severe-combined immunodeficient (SCID) mice to examine the immunoregulatory effects of interleukin (IL)-10 on innate resistance to infection with Listeria monocytogenes. Addition of heat killed Listeria to spleen cells from naive SCID mice resulted in secretion of interferon (IFN)-gamma from natural killer cells in vitro. This response was enhanced up to 15-fold in the presence of exogenous IL-2, but was completely ablated by addition of IL-10 with IC50 of less than 0.5 U/ml. Infection of SCID mice with viable Listeria in vivo resulted in a prolonged course of infection eventually causing death by 12-14 days, whereas daily administration of IL-10 increased bacterial replication in the liver and spleen by up to 1000-fold resulting in death by day 4 post-infection. The immunosuppressive actions of IL-10 in vivo were also observed in immunocompetent BALB/c mice, whereas doses as low as 100 U/day converted a sublethal infection to 100% mortality. To study the events controlling expression of endogenous IL-10, peritoneal macrophage monolayers were challenged with Listeria after preincubation with a panel of recombinant cytokines. IFN-gamma primed macrophages for enhanced tumor necrosis factor (TNF) secretion, but inhibited IL-10 production, whereas granulocyte/macrophage colony-stimulating factor (CSF), macrophage CSF and also IL-4 enhanced macrophage IL-10 responses after ingestion of Listeria in vitro. Finally, monoclonal antibody neutralization of IFN-gamma during infection of SCID mice with Listeria inhibited TNF-alpha mRNA, but augmented expression of IL-10 mRNA in infected tissues. These results demonstrate that exogenous Il-10 is a potent immunosuppressive cytokine in the context of infection with an intracellular bacterium and that expression of endogenous IL-10 versus TNF is differentially regulated by the cytokine environment of the macrophage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617304     DOI: 10.1002/eji.1830260214

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Interleukin 10 treatment for rheumatoid arthritis.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

Review 3.  Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; Rick A Wetsel
Journal:  Immunobiology       Date:  2016-07-16       Impact factor: 3.144

4.  Interleukin-10 has different effects on proliferation of Listeria monocytogenes in livers and spleens of mice.

Authors:  J N Samsom; A Annema; M F Geertsma; J A Langermans; P H Groeneveld; E de Heer; R van Furth
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma.

Authors:  D Smith; H Hänsch; G Bancroft; S Ehlers
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

6.  High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression.

Authors:  Maria del Pilar Jimenez; Lorraine Walls; Joshua Fierer
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant.

Authors:  J M Brewer; M Conacher; M Gaffney; M Douglas; H Bluethmann; J Alexander
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

8.  Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.

Authors:  Dennis W Metzger; Sharon L Salmon; Girish Kirimanjeswara
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

9.  Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.

Authors:  Soo M Ngoi; Michael G Tovey; Anthony T Vella
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  IL-10 helps control pathogen load during high-level bacteremia.

Authors:  Diana Londoño; Adriana Marques; Ronald L Hornung; Diego Cadavid
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.